JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB45690

Anti-CCL4/MIP-1 beta antibody [EP521Y]

1

(1 Review)

|

(14 Publications)

Rabbit Recombinant Monoclonal CCL4/MIP-1 beta antibody. Suitable for IP, ELISA, WB, ICC/IF and reacts with Human, Mouse samples. Cited in 14 publications.

View Alternative Names

LAG1, MIP1B, SCYA4, CCL4, C-C motif chemokine 4, G-26 T-lymphocyte-secreted protein, HC21, Lymphocyte activation gene 1 protein, MIP-1-beta(1-69), Macrophage inflammatory protein 1-beta, PAT 744, Protein H400, SIS-gamma, Small-inducible cytokine A4, T-cell activation protein 2, LAG-1, MIP-1-beta, ACT-2

7 Images
Immunocytochemistry/ Immunofluorescence - Anti-CCL4/MIP-1 beta antibody [EP521Y] (AB45690)
  • ICC/IF

Unknown

Immunocytochemistry/ Immunofluorescence - Anti-CCL4/MIP-1 beta antibody [EP521Y] (AB45690)

Immunocytochemistry/Immunofluorescence analysis of THP-1 (Human monocytic leukemia cell line) cells labeling CCL4/MIP-1 beta + CCL4L with ab45690 at 1/100. Cells were fixed with 4% Paraformaldehyde and permeabilized with 0.1% Triton X-100. ab150077 Alexa Fluor® 488-conjugated goat anti-rabbit IgG (1/1000) was used as the secondary antibody. Cells were counter-stained with ab7291 ab195889 Anti-alpha Tubulin antibody [DM1A] - Microtubule Marker (Alexa Fluor® 594) at 1/200 dilution. DAPI was used to stain nuclei blue.

The expression increased after treatment with Lipopolysaccharides (LPS) 100 ng/mL for 4 hours followed by addition of Brefeldin A (1 μg/mL) for 3 hours.

Immunoprecipitation - Anti-CCL4/MIP-1 beta antibody [EP521Y] (AB45690)
  • IP

Lab

Immunoprecipitation - Anti-CCL4/MIP-1 beta antibody [EP521Y] (AB45690)

ab45690 at 1/60 immunoprecipitating CCL4/MIP-1 beta + CCL4L in THP-1 (Human monocytic leukemia cell line) whole cell lysate observed at 12 KDa (lanes 1 and 2).

Lane 1 (input) : THP-1 treated with 100 nM PMA overnight, then treated with 100 ng/mL LPS for 7 hours and 1 μg/mL Brefeldin A was added for the last 3 hours whole cell lysate, 10μg

Lane 2 (+) : ab45690 + THP-1 treated with 100 nM PMA overnight, then treated with 100 ng/mL LPS for 7 hours and 1 μg/mL Brefeldin A was added for the last 3 hours whole cell lysate

Lane 3 (-) : Rabbit monoclonal IgG (ab172730) instead of ab45690 in THP-1 treated with 100 nM PMA overnight, then treated with 100 ng/mL LPS for 7 hours and 1 μg/mL Brefeldin A was added for the last 3 hours whole cell lysate

For western blotting, ab45690 at 1/1000 and ab131366 VeriBlot for IP Detection Reagent (HRP) was used for detection (1/1000).

Blocking/Diluting buffer 5% NFDM/TBST

All lanes:

Immunoprecipitation - Anti-CCL4/MIP-1 beta antibody [EP521Y] (ab45690)

Predicted band size: 10 kDa

false

Exposure time: 3min

ELISA - Anti-CCL4/MIP-1 beta antibody [EP521Y] (AB45690)
  • ELISA

Lab

ELISA - Anti-CCL4/MIP-1 beta antibody [EP521Y] (AB45690)

ELISA analysis of Human CCL4/MIP-1 beta recombinant protein at 500 ng/mL with ab45690. An Alkaline Phosphatase-conjugated AffiniPure Goat Anti-Rabbit IgG (H+L) at 1/2500 dilution was used as the secondary antibody.

Western blot - Anti-CCL4/MIP-1 beta antibody [EP521Y] (AB45690)
  • WB

Lab

Western blot - Anti-CCL4/MIP-1 beta antibody [EP521Y] (AB45690)

Blocking/Diluting buffer and concentration 5% NFDM /TBST.

CCL4/MIP-1 beta is induced in macrophages following exposure to bacterial LPS (PMID : 9848081).

All lanes:

Western blot - Anti-CCL4/MIP-1 beta antibody [EP521Y] (ab45690) at 1/1000 dilution

Lane 1:

Untreated THP-1 (human acute monocytic leukemia) cell lysate at 10 µg

Lane 2:

THP-1 treated with 100 nM Phorbol-12-myristate-13-acetate(PMA) overnight, then treated with Lipopolysaccharides (LPS) 100 ng/mL for 7 hours and then 1 µg/mL Brefeldin A was added for the last 3 hours, lysate at 10 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution

Predicted band size: 10 kDa

Observed band size: 12 kDa

false

Exposure time: 3min

Western blot - Anti-CCL4/MIP-1 beta antibody [EP521Y] (AB45690)
  • WB

Lab

Western blot - Anti-CCL4/MIP-1 beta antibody [EP521Y] (AB45690)

False colour image of Western blot : Anti-CCL4/MIP-1 beta antibody [EP521Y] staining at 1/1000 dilution, shown in green; Mouse anti-Alpha Tubulin [DM1A] (ab7291) loading control staining at 1/20000 dilution, shown in red. In Western blot, ab45690 was shown to bind specifically to CCL4/MIP-1 beta. A band was observed at 12 kDa in wild-type THP-1 cell lysates with no signal observed at this size in CCL4 knockout cell line ab273719 (knockout cell lysate ab275512). To generate this image, wild-type and CCL4 knockout THP-1 cell lysates were analysed. First, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 3 % milk in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed (ab216776) at 1/20000 dilution.

All lanes:

Western blot - Anti-CCL4/MIP-1 beta antibody [EP521Y] (ab45690) at 1/1000 dilution

Lane 1:

Wild-type THP-1 Vehicle control + Brefeldin A (5 u/mL, 6 h) cell lysate at 20 µg

Lane 2:

Wild-type THP-1 Treated PMA (100 ng/mL, 56 h) + LPS (1 u/mL, 24 h) + Brefeldin A (5 u/mL, 6 h) cell lysate at 20 µg

Lane 2:

Western blot - Human CCL4 knockout THP-1 cell line (<a href='/en-us/products/cell-lines/human-ccl4-knockout-thp-1-cell-line-ab273719'>ab273719</a>)

Lane 3:

CCL4 knockout THP-1 Vehicle control + Brefeldin A (5 u/mL, 6 h) cell lysate at 20 µg

Lane 4:

CCL4 knockout THP-1 Treated PMA (100 ng/mL, 56 h) + LPS (1 u/mL, 24 h) + Brefeldin A (5 u/mL, 6 h) cell lysate at 20 µg

Predicted band size: 10 kDa

Observed band size: 12 kDa

false

Western blot - Anti-CCL4/MIP-1 beta antibody [EP521Y] (AB45690)
  • WB

Lab

Western blot - Anti-CCL4/MIP-1 beta antibody [EP521Y] (AB45690)

Blocking/Diluting buffer and concentration 5% NFDM /TBST

All lanes:

Western blot - Anti-CCL4/MIP-1 beta antibody [EP521Y] (ab45690) at 1/1000 dilution

Lane 1:

Untreated Raw264.7 (mouse abelson murine leukemia virus-induced tumor) whole cell lysate at 10 µg

Lane 2:

Raw264.7 (mouse abelson murine leukemia virus-induced tumor) treated with LPS 10μg/mL for 4 hours and then 1 μg/mL Brefeldin A was added for the last 3 hours lysate at 10 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution

Predicted band size: 10 kDa,18 kDa,25 kDa,55 kDa,57 kDa

Observed band size: 12 kDa,18 kDa,26 kDa,90 kDa

false

Exposure time: 3min

Western blot - Anti-CCL4/MIP-1 beta antibody [EP521Y] (AB45690)
  • WB

Lab

Western blot - Anti-CCL4/MIP-1 beta antibody [EP521Y] (AB45690)

Blocking/Diluting buffer and concentration 5% NFDM /TBST

All lanes:

Western blot - Anti-CCL4/MIP-1 beta antibody [EP521Y] (ab45690) at 1/1000 dilution

Lane 1:

Untagged human CCL4 recombinant protein (aa24-92) at 10 µg

Lane 2:

Untagged human CCL4L recombinant protein (aa24-92) at 10 µg

Lane 3:

GST-tagged human CCL3 recombinant protein (aa27-92) at 10 µg

Lane 4:

GST-tagged human CCL3L recombinant protein 2*(aa28-93) at 10 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution

Predicted band size: 10 kDa

Observed band size: 12 kDa

false

Exposure time: 5s

  • Carrier free

    Anti-CCL4/MIP-1 beta antibody [EP521Y] - BSA and Azide free

  • 665 Alexa Fluor® 647

    Alexa Fluor® 647 Anti-CCL4/MIP-1 beta antibody [EP521Y]

  • 660 APC

    APC Anti-CCL4/MIP-1 beta antibody [EP521Y]

  • 519 Alexa Fluor® 488

    Alexa Fluor® 488 Anti-CCL4/MIP-1 beta antibody [EP521Y]

  • 565 Alexa Fluor® 555

    Alexa Fluor® 555 Anti-CCL4/MIP-1 beta antibody [EP521Y]

  • 578 PE

    PE Anti-CCL4/MIP-1 beta antibody [EP521Y]

  • 617 Alexa Fluor® 594

    Alexa Fluor® 594 Anti-CCL4/MIP-1 beta antibody [EP521Y]

Key facts

Host species

Rabbit

Clonality

Monoclonal

Clone number

EP521Y

Isotype

IgG

Carrier free

No

Reacts with

Mouse, Human

Applications

WB, ELISA, ICC/IF, IP

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IP" : {"fullname" : "Immunoprecipitation", "shortname":"IP"}, "ELISA" : {"fullname" : "ELISA", "shortname":"ELISA"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"}, "FlowCytIntra" : {"fullname" : "Flow Cytometry (Intracellular)", "shortname":"Flow Cyt (Intra)"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IP-species-checked": "testedAndGuaranteed", "IP-species-dilution-info": "1/60", "IP-species-notes": "<p></p>", "ELISA-species-checked": "testedAndGuaranteed", "ELISA-species-dilution-info": "", "ELISA-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000 - 1/500000", "WB-species-notes": "<p></p>", "ICCIF-species-checked": "testedAndGuaranteed", "ICCIF-species-dilution-info": "1/100", "ICCIF-species-notes": "<p></p>", "FlowCytIntra-species-checked": "notRecommended", "FlowCytIntra-species-dilution-info": "", "FlowCytIntra-species-notes": "<p></p>" }, "Mouse": { "IP-species-checked": "guaranteed", "IP-species-dilution-info": "", "IP-species-notes": "", "ELISA-species-checked": "guaranteed", "ELISA-species-dilution-info": "", "ELISA-species-notes": "", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000 - 1/500000", "WB-species-notes": "<p></p>", "ICCIF-species-checked": "guaranteed", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "", "FlowCytIntra-species-checked": "notRecommended", "FlowCytIntra-species-dilution-info": "", "FlowCytIntra-species-notes": "<p></p>" } } }

Product details

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Storage buffer
pH: 7.2 - 7.4 Preservative: 0.01% Sodium azide Constituents: PBS, 50% Glycerol (glycerin, glycerine), 0.05% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

CCL4 also known as MIP-1 beta or MIP-1b has a mechanical role as a chemokine involved in immune response regulation. The protein has a mass of about 7.8 kDa. It expresses in various tissues including leukocytes where it mainly functions as a chemoattractant. MIP-1 beta helps recruit immune cells like natural killer cells and monocytes to sites of inflammation or injury. Researchers frequently measure its levels using assays like MIP-1 beta ELISA or CCL4 ELISA.
Biological function summary

CCL4 is critical in immune system modulation. It coordinates leukocyte activation and trafficking contributing to inflammation and immune surveillance. It does not function in isolation but rather interacts with other chemokines and receptors. CCL4 alongside its sibling chemokines forms a dynamic network that ensures a balanced immune response. It connects to receptors such as CCR5 playing substantial roles in its activities.

Pathways

CCL4 participates in essential signaling cascades that mediate immune responses. It is notably part of the chemokine signaling pathway which is instrumental in directing cell movement. CCL4 also engages with proteins like CCR5 in the inflammatory and immune response pathways. This interaction enhances communication between cells required for effective pathogen defense.

CCL4 plays roles in immune-related conditions. It is strongly linked to inflammatory diseases such as rheumatoid arthritis and HIV infection. In rheumatoid arthritis CCL4 levels are often elevated correlating with inflammation severity. During HIV infection CCL4 interacts with proteins like CCR5 a co-receptor the virus uses to enter host cells. This involvement makes MIP-1 beta a target for studies seeking therapeutic interventions in these diseases.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Monokine with inflammatory and chemokinetic properties. Binds to CCR5. One of the major HIV-suppressive factors produced by CD8+ T-cells. Recombinant MIP-1-beta induces a dose-dependent inhibition of different strains of HIV-1, HIV-2, and simian immunodeficiency virus (SIV). The processed form MIP-1-beta(3-69) retains the abilities to induce down-modulation of surface expression of the chemokine receptor CCR5 and to inhibit the CCR5-mediated entry of HIV-1 in T-cells. MIP-1-beta(3-69) is also a ligand for CCR1 and CCR2 isoform B.
See full target information CCL4

Publications (14)

Recent publications for all applications. Explore the full list and refine your search

Nature communications 16:3516 PubMed40229254

2025

Parallel comparison of T cell and B cell subpopulations of adenoid hypertrophy and tonsil hypertrophy of children.

Applications

Unspecified application

Species

Unspecified reactive species

Zihui Yu,Ziying Xu,Tongtong Fu,Shiyu Liu,Jinghua Cui,Bing Zhang,Jieqiong Liang,Chong Pang,Yuehua Ke,Ruikun Wang,Zhijie Tang,Yagang Gao,Bing Du,Yanling Feng,Hanqing Zhao,Guanhua Xue,Chao Yan,Lin Gan,Junxia Feng,Zheng Fan,Yang Yang,Lijuan Huang,Shuo Zhao,Sun Ying,Qinglong Gu,Jing Yuan

Cell death & disease 16:175 PubMed40089481

2025

Genetic deletion of G protein-coupled receptor 56 aggravates traumatic brain injury through the microglial CCL3/4/5 upregulation targeted to CCR5.

Applications

Unspecified application

Species

Unspecified reactive species

Zhuang Sha,Shiying Dong,Meng Nie,Tao Liu,Chenrui Wu,Chuanxiang Lv,Mingqi Liu,Weiwei Jiang,Jiangyuan Yuan,Yu Qian,Xianhua Piao,Rongcai Jiang,Chuang Gao

International journal of molecular sciences 24: PubMed37373025

2023

Thymoquinone Inhibition of Chemokines in TNF-α-Induced Inflammatory and Metastatic Effects in Triple-Negative Breast Cancer Cells.

Applications

Unspecified application

Species

Unspecified reactive species

Getinet M Adinew,Samia Messeha,Equar Taka,Bereket Mochona,Kinfe K Redda,Karam F A Soliman

Mediators of inflammation 2022:1875736 PubMed36387933

2022

Retinoic Acid Receptor Gamma (RAR) Promotes Cartilage Destruction through Positive Feedback Activation of NF-B Pathway in Human Osteoarthritis.

Applications

Unspecified application

Species

Unspecified reactive species

Yue-Wei Yu,Si-Yang Li,Lin-Jun Zhang,Qian-Liang Wang,Zhong-Guo Liu,Qing-Zhi Chen,Hong-Yu Song,Dong-Yan Shen,Jun Yan

Journal of oncology 2022:5864826 PubMed36131790

2022

SLC7A1 Overexpression Is Involved in Energy Metabolism Reprogramming to Induce Tumor Progression in Epithelial Ovarian Cancer and Is Associated with Immune-Infiltrating Cells.

Applications

Unspecified application

Species

Unspecified reactive species

Shijing You,Xiaoying Zhu,Yao Yang,XiuZhen Du,Kejuan Song,Qingmei Zheng,Pengjiao Zeng,Qin Yao

Immunity & ageing : I & A 19:34 PubMed35879802

2022

Aged microglia promote peripheral T cell infiltration by reprogramming the microenvironment of neurogenic niches.

Applications

Unspecified application

Species

Unspecified reactive species

Xiaotao Zhang,Rui Wang,Haoran Chen,Chenghao Jin,Ziyang Jin,Jianan Lu,Liang Xu,Yunrong Lu,Jianmin Zhang,Ligen Shi

Frontiers in molecular biosciences 8:697273 PubMed34790697

2021

Long Non-Coding RNA MEG8 Suppresses Hypoxia-Induced Excessive Proliferation, Migration and Inflammation of Vascular Smooth Muscle Cells by Regulation of the miR-195-5p/RECK Axis.

Applications

Unspecified application

Species

Unspecified reactive species

Dexing Xu,Ruozhu Dai,Hao Chi,Wen Ge,Jingfeng Rong

Frontiers in molecular biosciences 8:682367 PubMed34179086

2021

The Inhibitory Effect of Lysophosphatidylcholine on Proangiogenesis of Human CD34 Cells Derived Endothelial Progenitor Cells.

Applications

Unspecified application

Species

Unspecified reactive species

Haijun Zhao,Yanhui He

Frontiers in cell and developmental biology 9:596484 PubMed33777927

2021

Immune Profiling Reveals Molecular Classification and Characteristic in Urothelial Bladder Cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Li Yang,Aitian Li,Fengsen Liu,Qitai Zhao,Shaofei Ji,Wen Zhu,Weina Yu,Ru Zhang,Yaqing Liu,Wencai Li,Yi Zhang

Frontiers in immunology 11:366 PubMed32194569

2020

Therapy With Carboplatin and Anti-PD-1 Antibodies Before Surgery Demonstrates Sustainable Anti-Tumor Effects for Secondary Cancers in Mice With Triple-Negative Breast Cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Meizhuo Gao,Tie Wang,Litong Ji,Shuping Bai,Lining Tian,Hongjiang Song
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com